Abstract: The present invention relates to novel benzimidazolone derivatives of the general formula (I) in which the substituents R1, R2, R3, A1, A2, and B are as defined in claim 1, medicaments comprising these, and the use thereof for the prophylaxis and/or treatment of vasopressin-dependent diseases.
Type:
Grant
Filed:
August 24, 2007
Date of Patent:
February 21, 2012
Assignee:
Abbott GmbH & Co. HG
Inventors:
Torsten Arndt, Thorsten Oost, Wilfried Lubisch, Wolfgang Wernet, Alfred Hahn, legal representative, Wilfried Hornberger, Liliane Unger, Juliana Ruiz Caro